Data / Drug companies / Nifedipine
Nifedipine: 38 companies and 133 products in the FDA NDC directory
Nifedipine is listed in the FDA National Drug Code Directory by 38 companies, with 133 products in commercial distribution. 131 of the products (98.5%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, extended release; tablet, film coated, extended release; capsule, and the newest product started marketing on May 11, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 38
- Products
- 133
- Generic (ANDA) products
- 131 (98.5%)
- Application numbers
- 17
- Routes
- Oral
- Brand names
- Procardia XL
- openFDA record search
- api.fda.gov
Companies that list nifedipine
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 7 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | March 30, 2022 |
| Bryant Ranch Prepack | 7 | tablet, extended release | Generic drugs (ANDA) | July 19, 2021 |
| Northwind Health Company, LLC | 7 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | March 28, 2023 |
| Aphena Pharma Solutions - Tennessee, LLC | 6 | tablet, extended release | Generic drugs (ANDA) | February 15, 2017 |
| Ingenus Pharmaceuticals, LLC | 6 | tablet, film coated, extended release; tablet, extended release | Generic drugs (ANDA) | March 12, 2019 |
| Upsher-Smith Laboratories, LLC | 6 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | November 1, 2014 |
| Zydus Lifesciences Limited | 6 | tablet, extended release | Generic drugs (ANDA) | August 18, 2018 |
| Zydus Pharmaceuticals USA Inc. | 6 | tablet, extended release | Generic drugs (ANDA) | August 18, 2018 |
| Bryant Ranch Prepack | 5 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | March 12, 2019 |
| Chartwell RX, LLC | 5 | tablet, film coated, extended release; capsule | Generic drugs (ANDA) | December 7, 2010 |
| Oceanside Pharmaceuticals | 5 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | October 18, 2012 |
| PD-Rx Pharmaceuticals, Inc. | 5 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | March 30, 2022 |
| Cardinal Health 107, LLC | 4 | tablet, film coated, extended release; capsule | Generic drugs (ANDA) | April 9, 2026 |
| Major Pharmaceuticals | 4 | tablet, film coated, extended release; capsule | Generic drugs (ANDA) | August 23, 2022 |
| Proficient Rx LP | 4 | tablet, extended release | Generic drugs (ANDA) | November 1, 2014 |
| Alembic Pharmaceuticals Inc. | 3 | tablet, extended release | Generic drugs (ANDA) | November 23, 2022 |
| Alembic Pharmaceuticals Limited | 3 | tablet, extended release | Generic drugs (ANDA) | November 23, 2022 |
| American Health Packaging | 3 | tablet, film coated, extended release | Generic drugs (ANDA) | September 9, 2013 |
| Ascend Laboratories, LLC | 3 | tablet, extended release | Generic drugs (ANDA) | March 30, 2022 |
| Aurobindo Pharma Limited | 3 | tablet, extended release | Generic drugs (ANDA) | July 19, 2021 |
| AvPAK | 3 | tablet, film coated, extended release | Generic drugs (ANDA) | February 11, 2011 |
| Golden State Medical Supply, Inc. | 3 | tablet, extended release | Generic drugs (ANDA) | August 25, 2016 |
| Golden State Medical Supply, Inc. | 3 | tablet, extended release | Generic drugs (ANDA) | April 3, 2014 |
| Lannett Company, Inc. | 3 | tablet, film coated, extended release | Generic drugs (ANDA) | October 3, 2007 |
| NuCare Pharmaceuticals,Inc. | 3 | tablet, extended release | Generic drugs (ANDA) | July 19, 2021 |
| Remedyrepack Inc. | 3 | tablet, extended release; capsule | Generic drugs (ANDA) | April 24, 2026 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 2 | capsule | Generic drugs (ANDA) | December 7, 2010 |
| Pfizer Laboratories Div Pfizer Inc | 2 | tablet, film coated, extended release | New drug applications (NDA) | September 6, 1989 |
| Preferred Pharmaceuticals Inc. | 2 | tablet, film coated, extended release | Generic drugs (ANDA) | April 4, 2022 |
| Redpharm Drug | 2 | tablet, extended release | Generic drugs (ANDA) | March 30, 2022 |
| St. Mary's Medical Park Pharmacy | 2 | tablet, film coated, extended release | Generic drugs (ANDA) | June 4, 2024 |
| Bryant Ranch Prepack | 1 | tablet, extended release | Generic drugs (ANDA) | October 18, 2012 |
| Coupler LLC | 1 | tablet, film coated, extended release | Generic drugs (ANDA) | May 11, 2026 |
| Elite Pharmaceutical Solution, Inc. | 1 | tablet, film coated, extended release | Generic drugs (ANDA) | October 15, 2021 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 1 | tablet, extended release | Generic drugs (ANDA) | March 12, 2019 |
| NuCare Pharmaceuticals, Inc. | 1 | capsule | Generic drugs (ANDA) | August 11, 2009 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet, film coated, extended release | Generic drugs (ANDA) | November 21, 2005 |
| Proficient Rx LP | 1 | tablet, film coated, extended release | Generic drugs (ANDA) | November 21, 2005 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, extended release | 84 | 63.2% |
| Tablet, film coated, extended release | 40 | 30.1% |
| Capsule | 9 | 6.8% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 131 | 98.5% |
| New drug applications (NDA) | 2 | 1.5% |
Pharmacologic classes
| Class | Products |
|---|---|
| Dihydropyridine Calcium Channel Blocker | 133 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.